[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin, 2020, 70: 7-30.
[2] Hamdy FC, Donovan JL, Lane JA et al.10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med, 2016, 375: 1415-1424.
[3] Wilt TJ, Jones KM, Barry MJ, et al. Follow-up of Prostatectomy versus Observation for Early Prostate Cancer. N Engl J Med, 2017, 377: 132-142.
[4] Yossepowitch O, Eggener SE, Bianco FJ et al. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. J Urol, 2007, 178: 493-9.
[5] Gandaglia G, Fossati N, Zaffuto E et al. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. Eur Urol, 2017, 72: 632-640.
[6] Mottet N, Bellmunt J, Bolla M et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol, 2017, 71: 618-629.
[7] Moris L, Cumberbatch MG, Van den BT et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol, 2020, 77: 614-627.
[8] Fossati N, Willemse PM, Van den BT et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol, 2017, 72: 84-109.
[9] Abdollah F, Gandaglia G, Suardi N et al. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. Eur Urol, 2015, 67: 212-9.
[10] Gakis G, Boorjian SA, Briganti A et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur Urol, 2014, 66: 191-9.
[11] Tyritzis SI, Wallerstedt A, Steineck G et al. Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection. J Urol, 2015, 193: 117-25.
[12] Yuh B, Artibani W, Heidenreich A et al. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. Eur Urol, 2014, 65: 918-27.
[13] Studer UE, Collette L, Whelan P et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol, 2008, 53: 941-9.
[14] Moschini M, Briganti A, Murphy CR et al. Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy. Eur Urol, 2016, 69: 193-6.
[15] Preisser F, van den BN, Gandaglia G et al. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study. J Urol, 2020, 203: 338-343.
[16] Mottet N, Bellmunt J, Briers E et al. Guidelines on Prostate Cancer. European Association of Urology. Available at: http://uroweb.org/.
[17] Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med, 2014, 33: 1242-58.
[18] Preisser F, Bandini M, Marchioni M et al. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. Prostate, 2018, 78: 469-475.
[19] Seyedin SN, Mitchell DL, Mott SL et al. Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone. Pathol Oncol Res, 2019, 25: 209-215.
[20] Chalouhy C, Gurram S, Ghavamian R, Current controversies on the role of lymphadenectomy for prostate cancer. Urol Oncol, 2019, 37: 219-226.
[21] Gigliarano C, Nonis A, Briganti A et al. Effect of the number of removed lymph nodes on prostate cancer recurrence and survival: evidence from an observational study. BMC Bioinformatics, 2018, 19: 200.
[22] Costello AJ, Considering the role of radical prostatectomy in 21st century prostate cancer care. Nat Rev Urol, 2020, 17: 177-188.